Aug 19, 2023, 20:05
Why patients with triple negative breast cancer respond differently to treatment. – The Institute of Cancer Research
The Institute of Cancer Research, made the following remark on Twitter:
“Our scientists have looked into better understanding why patients with triple negative breast cancer respond differently to treatment, in a new study run by The Institute of Cancer Research Clinical Trials and Statistics Unit.
The findings could help accelerate the development of more personalised treatments.”
For full article: Click here
Source: The Institute of Cancer Research / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33